Opinion: Top 2 takeaways from UBS Global Healthcare Conference
June 16, 2017
The conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Marc O'Connor
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy Summit
May 20, 2017
The conference raised important points about value-based contracts and the specialty pharmacy space.
Value-based care takes over J.P. Morgan Healthcare Conference 2017
January 23, 2017
Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
Three issues to watch at the J.P. Morgan Healthcare Conference 2017
January 3, 2017
This year’s J.P. Morgan Healthcare Conference will address some of the biggest managed care trends, including next-gen at-risk contracts and access to therapy as cancer trends towards a chronic condition.
What billions in lost pharma revenue means for managed care
December 12, 2016
Pharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.
Real-world results determine value-based price for specialty drugs
July 1, 2016
In an era when adherence to specialty pharmaceuticals is disturbingly low, value-based pricing needs real-world results, not single-arm accelerated trials.
Four critical components for successful, value-based pharma contracts
June 1, 2016
Despite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.
Opinion: Top 4 lessons learned from Asembia 2016
May 13, 2016
Insights from the 2016 edition of the largest gathering in specialty pharmacy.
Are your prior auth provisions stifling medication adherence?
March 8, 2016
Prior authorizations are here to stay. Are yours working against you? Find out.
How to make value-based care more valuable
December 9, 2015
Here are the top 3 value-based healthcare developments of 2015 and the top 3 ways to advance value-based care in 2016.
